Texray has developed a patented radiation-protection textile designed to improve comfort and safety for healthcare professionals exposed to X-ray radiation during surgical interventions. Its material is used in products for medical personnel and may also serve professionals in nuclear, aerospace, and space sectors. The technology emphasizes a high level of protection while prioritizing wearer comfort and well-being. Texray's platform has secured CE and FDA registrations and regulatory approvals across Europe, Japan, and the US. The company is led by CEO Petra Apell and is based in Gothenburg, Sweden. It intends to use the new funding to expand operations and broaden its business reach.

Total raised

$4M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2023